BackAlpine Immune Sciences Overview

Alpine Immune Sciences Receivables

Alpine Immune Sciences's receivables is $540K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$543000.00
23.84% YoYΔ $-170000.00 vs prior year quarter

Peer average

Loading

Alpine Immune Sciences Receivables History

Loading

Alpine Immune Sciences vs. peers: Receivables Comparison

Loading

Alpine Immune Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alpine Immune Sciences (ALPN) FAQ

As of the most recent data (March 2024), ALPN shows a receivables of $540K. That compares with $710K in the prior-year period — down 23.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALPN's receivables is now $540K (was $710K) — a 23.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Alpine Immune Sciences is outperforming or lagging.

Tracking ALPN's receivables over time shows whether Alpine Immune Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $540K That compares with $710K in the prior-year period — down 23.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Alpine Immune Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $540K) with ownership activity and broader fundamentals.

Alpine Immune Sciences's receivables is $540K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.